Market Place
Sourcing Support
Gene therapy reduces seizures in mice with severe epilepsy
09 Dec 2024 //
FIERCE BIOTECH
Capsida Bio Presents Preclinical Data for Friedreich’s Gene Therapy
12 Nov 2024 //
PR NEWSWIRE
Capsida cuts staff even with AbbVie, Lilly deals on the books
14 Jul 2023 //
FIERCE BIOTECH
Capsida lays off workers after expanding AbbVie pact, adding Lilly collab
28 Jun 2023 //
ENDPTS
Capsida Biotherapeutics Appoints Susan Catalano as Chief Scientific Officer
07 Mar 2023 //
PR NEWSWIRE
Capsida Biotherapeutics Names Susan Catalano Chief Scientific Officer
07 Mar 2023 //
CONTRACT PHARMA
AbbVie pays $70M to expand Capsida collab into eye disease
24 Feb 2023 //
FIERCE BIOTECH
Capsida Announces Appointment of Julie Hakim as Chief Financial Officer
18 Jan 2023 //
PR NEWSWIRE
Prevail, Capsida partner to develop gene therapies for nervous system diseases
05 Jan 2023 //
BIOPHARMADIVE
Capsida Biotherapeutics Presents Data on Unique Industry-Leading Technology
18 May 2022 //
PRNEWSWIRE
Capsida Bio Presents New Data Validating Potential of Gene Therapy Platform
17 May 2022 //
PRNEWSWIRE
Capsida Unveils Next-Generation Gene Therapy Manufacturing
27 Jul 2021 //
CONTRACT PHARMA
Capsida Biotherapeutics Opens Facility in Thousand Oaks
23 Jul 2021 //
CONTRACT PHARMA
CRISPR Therapeutics discovery deal with AAV upstart Capsida
16 Jun 2021 //
ENDPTS
CRISPR Therapeutics takes a swing at gene editing in discovery deal with Capsida
15 Jun 2021 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.